AdaptHealth (AHCO) Insider Theodore Lundberg Buys 18,999 Shares
Insider Theodore Lundberg purchased 18,999 shares of AdaptHealth Corp. on June 24, 2026, adding to a growing trend of insider buying.
Reviewed by automated data checks against the source filing. How we make and check alerts
Theodore Lundberg bought 18,999 shares of AdaptHealth Corp. ($AHCO) on June 24, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $AHCO is up 5.7% after 1 week, up 7.3% after 1 month and down 40.0% to date (from the $10.03 close on Jun 24, 2026).
AHCO
AdaptHealth Corp.
Key Points
- Theodore Lundberg bought 18,999 shares of AdaptHealth Corp. on June 24, 2026, at a price of $10.29 each, totaling nearly $195,000.
- AdaptHealth Corp. has seen a 127% revenue growth over the past year, yet reported a net loss margin of 6.8%.
- Analysts maintain a consensus rating of 'strong buy' for AdaptHealth with a mean price target of $9.00, indicating optimism despite recent price adjustments.
Get $AHCO trade alerts by text
We text you when insiders, Congress or big funds trade $AHCO. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated AdaptHealth Corp. alert may contain errors. Disclosures
Insider Buying and Selling at AdaptHealth Corp.
On June 24, 2026, Theodore Lundberg purchased 18,999 shares of AdaptHealth Corp. (NasdaqCM: AHCO) at a price of $10.29 each. This transaction reflects a total investment of nearly $195,000. The purchase adds to a series of insider transactions on the same day, showing a strong interest from multiple executives in the company's future.
Multiple Insiders Buying on the Same Day
On the same day as Lundberg's purchase, several other insiders also bought shares of AdaptHealth. Gregory Belinfanti, Terence Connors, Bradley Coppens, Susan Weaver, and Williams David Solomon III each acquired 18,999 shares. This collective buying indicates a notable level of confidence among the company's insiders.
Stock Performance and Market Context
AdaptHealth's shares are currently trading at $10.29, situated between its 52-week low of $5.21 and high of $13.43. The stock has recently shown strength, moving up from its previous close of $5.71. This uptick may reflect positive sentiment following the insider purchases and the company's revenue growth, despite its ongoing challenges with profitability.
Analysts Set New Price Targets
Analysts have a generally positive outlook on AdaptHealth. On September 17, 2026, Baird maintained an 'Outperform' rating with a target price of $9.00, down from $10.00. UBS also kept its 'Buy' rating but lowered its target to $10.00 from $14.00 on August 6, 2026. Overall, the consensus rating remains a 'strong buy' with a mean target price of $9.00, reflecting optimism about the company's growth potential despite recent adjustments.
What AdaptHealth Corp. Does
AdaptHealth Corp. distributes home medical equipment and supplies across the United States. Its products range from sleep therapy devices to diabetes management tools. The recent insider buying may signal confidence in the company’s strategies to navigate its market challenges.
What’s Next for AdaptHealth
Looking ahead, investors will be watching for the next earnings report scheduled for November 3, 2026. The recent insider buying trend, alongside the upcoming earnings announcement, will likely keep AdaptHealth in focus. It's important to remember that these filings reflect past positions and may not represent current holdings.
Related Filing Alerts
Source: Theodore Lundberg's Form 4 filing on $AHCO (Jun 24, 2026). Find the original filing: AHCO Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts